Navigation Links
Solos Endoscopy Finishes the 3rd Quarter With a Net Profit
Date:11/22/2011

BOSTON, Nov. 22, 2011 /PRNewswire/ -- Solos Endoscopy, Inc.'s (OTCPK: SNDY) is pleased to announce that it finished the 3rd Quarter with a Net Profit of $73,895.  Solos Endoscopy has consummated agreements which resulted in the Forgiveness of debt of $299,082 for the Three Months period ending September 30, 2011.  The signed settlement agreement and new consulting agreement result in a reduction of ongoing expenses by approximately $40,000 per quarter.

Solos Endoscopy posted its financial statements for period ended September 30, 2011.  While the Company saw a modest decrease in sales over the three month period, the Net Profit is a result of Management's cost cutting and debt reduction efforts.  Management is extremely pleased with the increase in demand for its new MammoView® instrument line.

The MammoView® instrument line, designed exclusively for breast endoscopy, has become crucial to early breast cancer screening as a method to significantly reduce breast cancer death rates. The Solos MammoView® Breast Endoscopy System is designed to distinguish and inspect suspicious pre-cancerous lesions that are undetectable by other methods as well as complement existing diagnosis and treatment options with direct endoscopic observation.

"Solos management has worked extremely hard to position the Company for future success.  This is represented by our tireless efforts to work with our creditors, while remaining focused on future product development. We have allocated significant resources to the development of the MammoView® instrument line.  The fact that we have taken this tremendous product from concept phase to sales in dozens of hospitals across the Country is truly amazing.  I'd like to thank the shareholders for all their continued support," stated Bob Segersten, President of Solos Endoscopy, Inc.

Please visit http://www.otcmarkets.com/stock/SNDY/financials for more information.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact: Amanda Segersten, rsegersten@solosendoscopy.com


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy Poised for Tremendous Growth in Multi-Billion Dollar Endoscopic Market
2. Solos Endoscopy Goes Google
3. Solos Endoscopy Finishes the 3rd Quarter Strong
4. Solos Endoscopy to Support National Breast Cancer Foundation With Sales of Its MammoView® Breast Endoscopy Components to US Hospitals
5. Solos Endoscopy to Market its MammoView® Breast Endoscopy Components to US Hospitals
6. Solos Endoscopy Reports 32% Increase in Breast Endoscopy Sales
7. Solos Endoscopy to Reduce Debt by Over $620,000
8. Solos Endoscopys MammoView® System Proves Crucial to Early Breast Cancer Detection
9. Lantus®/Apidra® SoloSTAR® Help to Improve Patient Satisfaction
10. Solos Endoscopy, Inc. To Launch New Corporate Website
11. Solos Endoscopy, Inc. Strengthens Current Line of Laparoscopic Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Research and Markets has announced the addition ... Demand Forecast to 2022" report to their offering. ... The global wound care market was worth ... CAGR of 6.7% during 2016-2022 Among the various wound care ... in the global market in 2015. Among the various applications, surgical wound ...
(Date:3/24/2017)... Research and Markets has announced the addition of ... their offering. ... analyzes the worldwide markets for Dental Implants in US$ Million. The report ... Japan , Europe , ... World. Annual estimates and forecasts are provided for the ...
(Date:3/24/2017)... 2017 ShangPharma, a leading life ... drug development and discovery services, technology, and ... announced today the intent for a strategic ... consolidating the Contract Research Organizations (CRO) and ... These entities include ChemPartner Shanghai, ChemPartner Fengxian, ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by ... it does not obey the rules Congress has directed the CBO to follow. The ... GOP reform would restore. Yet, it estimates a reduction in employer-based coverage due to ...
(Date:3/24/2017)... Orion, MI (PRWEB) , ... March 24, 2017 ... ... insurance assistance, financial planning, and related services to families and business owners across ... initiative aimed at feeding regional families struggling with financial difficulties. , The Oxford/Orion ...
(Date:3/24/2017)... Pittsburgh, PA (PRWEB) , ... March 24, 2017 ... ... the Oncology Nursing Society (ONS) wanted to create a communications platform that positions ... realize this goal, Elliance and ONS reinvented their online publication as an always-on, ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of Enea, ... pleased to announce Westchester resident Lauren C. Enea has joined the firm as an ... will concentrate her practice in elder law, Medicaid planning and applications, and Wills, Trusts ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... the year of enhancements, upgrading their training and leads programs. , In February, ... Reserved for elite sales agents, Performance Partners is designed to teach how to ...
Breaking Medicine News(10 mins):